We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

Product News   Jun 20, 2018

 
CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

Credit: CIRCULOGENE

 
 
FURTHER INFORMATION
 
 
 

Related Product News

INTEGRA Simplifies Pipetting for GLP Environments

Product News

INTEGRA’s electronic pipettes – including the VIAFLO, VOYAGER and VIAFLO 96/384 ranges – are designed to meet the demands of the modern laboratory environment.

READ MORE

Corning Introduces New 1536-well Spheroid Microplate

Product News

High-throughput spheroid microplate benefits cancer research, drug screening.

READ MORE

IncellDx Launches BioINK PD-L1 CTC Core Kit with Lyophilized CTC Control Cells for Microfluidic Liquid Biopsies

Product News

IncellDx has launched a complete, pre-optimized kit to identify, enumerate, and quantify the important tumor therapeutic target PD-L1 on circulating tumor cells (CTCs).

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE